Jalid Sehouli, Prof. Dr. med.

Lead coordinating investigator (LKP) according to AMG and representative of the sponsor · Frauenklinik

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

PubMed author-name match

Trials

Studies that name Jalid Sehouli, Prof. Dr. med. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:29 UTC. Open this list on ClinicalTrials.gov

Ph2
NCT05460000 · A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy
North Eastern German Society of Gynaecological Oncology · recruiting · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma · principal investigator
Ph2
NCT03622931 · Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH · terminated · Ovarian Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name.